Insulin-like growth factors in embryonic and fetal growth and skeletal development (Review)

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 579-584

  Agrogiannis, Georgios D ^a   Sifakis, Stavros ^b   Patsouris, Efstratios S ^a   Konstantinidou, Anastasia E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Fetal growth; Insulin like growth factor I; Insulin like growth factor II; Insulin like growth factors; Skeletal development

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

BLOOD LEVEL; BONE DEVELOPMENT; BONE GROWTH; BONE LENGTH; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; EMBRYO GROWTH; FETUS (ANATOMY); FETUS BLOOD; FETUS CELL; FETUS GROWTH; GENE EXPRESSION; GENETIC DISORDER; HUMAN; LIMB DEVELOPMENT; MORPHOGENESIS; NONHUMAN; PREIMPLANTATION EMBRYO; PROTEIN EXPRESSION; REVIEW; ANIMAL; FEMUR; FETUS DEVELOPMENT; GENETICS; HAPLOINSUFFICIENCY; METABOLISM;

ANIMALS; FEMUR; FETAL DEVELOPMENT; HAPLOINSUFFICIENCY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II;

EID: 84903269110     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2258     Document Type: Review

References (79)

1. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
2. LeRoith D, Werner H, Beitner-Johnson and Roberts CT Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143-163, 1995.
3. Kornfeld S: Structure and function of the mannose-6-phosphate/insulin- like growth factor II receptors. Annu Rev Biochem 61: 307-330, 1992.
4. Efstratiadis A: Genetics of mouse growth. Int J Dev Biol 42: 955-976, 1998.
5. Davies SM: Developmental regulation of genomic imprinting of the Igf2 gene in human liver. Cancer Res 54: 2560-2562, 1994.
6. Vetter U, Zapf J, Heit W, et al: Human fetal and adult chondrocytes. Effect of insulin-like growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest 77: 1903-1908, 1986. (Pubitemid 16062646)
7. Bhaumick B and Bala RM: Differential effects of insulin-like growth factors I and II on growth, differentiation and glucoregulation in differentiating chondrocyte cells in culture. Acta Endocrinol (Copenh) 125: 201-211, 1991.
8. Lorenzo M, Valverde AM, Ternel T and Benito M: IGF-I is a mitogen involved in differentiation-related gene expression in fetal rat brown adipocytes. J Cell Biol 123: 1567-1575, 1993. (Pubitemid 24012033)
9. Harvey MB and Kaye PL: Insulin-like growth factor-1 stimulates growth of mouse preimplantation embryos in vitro. Mol Reprod Dev 31: 195-199, 1992.
10. Canalis E, McCarthy T and Centrella M: Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae. Endocrinology 122: 22-27, 1988. (Pubitemid 18027578)
11. D'Ercole AJ, Applewhite GT and Underwood LE: Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol 75: 315-328, 1980. (Pubitemid 10115557)
12. DeChiara TM, Efstratiadis A and Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80, 1990.
13. Liu J-P, Baker J, Perkins AS, Roberson EJ and Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72, 1993. (Pubitemid 23306021)
14. Baker J, Liu J-P, Robertson EJ and Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82, 1993. (Pubitemid 23306022)
15. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr and Leibel RL: Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 12: 88-90, 1996. (Pubitemid 26011326)
16. Savage MO, Blum WF, Ranke MB, et al: Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 77: 1465-1471, 1993. (Pubitemid 24000897)
17. Sanders EJ and Harvey S: Growth hormone as an early embryonic growth and differentiation factor. Anat Embryol (Berl) 209: 1-9, 2004. (Pubitemid 40064367)
18. Walenkamp MJ, Karperien M, Pereira AM, et al: Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 90: 2855-2864, 2005. (Pubitemid 40686336)
19. Bhakta KY, Marlin SJ, Shen JJ and Fernandes CJ: Terminal deletion of chromosome 15q26.1: case report and brief literature review. J Perinatol 25: 429-432, 2005. (Pubitemid 40862211)
20. Gluckman PD and Butler JH: Parturition-related changes in insulin-like growth factors-I and -II in the perinatal lamb. J Endocrinol 99: 223-232, 1983. (Pubitemid 14246853)
21. Holland MD, Hossner KL, Williams SE, Wallace CR, Niswender GD and Odde KG: Serum concentrations of insulin-like growth factors and placental lactogen during gestation in cattle. Domest Anim Endocrinol 14: 231-239, 1997. (Pubitemid 29318753)
22. Lee CY, Chung CS and Simmen FA: Ontogeny of the porcine insulin-like growth factor system. Mol Cell Endocrinol 93: 71-80, 1993. (Pubitemid 23148883)
23. Moses AC, Nissley SP, Short PA, et al: Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. Proc Natl Acad Sci USA 77: 3649-3653, 1980. (Pubitemid 10012915)
24. Daughaday WH, Parker KA, Borowsky S, Trivedi B and Kapadia M: Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction. Endocrinology 110: 575-581, 1982. (Pubitemid 12162954)
25. Lund PK, Moats-Staats BM, Hynes MA, et al: Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 261: 14539-14544, 1986. (Pubitemid 17220240)
26. Gluckman PD, Johnson-Barrett JJ, Butler JH, Edgar BW and Gunn TR: Studies of insulin-like growth factor-I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxf) 19: 405-413, 1983. (Pubitemid 13037235)
27. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F and Binoux M: Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29: 219-225, 1991.
28. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R and van Assche FA: C-peptide, the insulin-like growth factors-I and -II, and IGF-binding protein I in umbilical cord serum: correlations with birthweight. Am J Obstet Gynecol 169: 89-97, 1993. (Pubitemid 23223934)
29. Giudice LC, de Zegher F, Gargosky SE, et al: Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80: 1548-1555, 1995.
30. Sifakis S, Akolekar R, Kappou D, Mantas N and Nicolaides KH: Maternal serum insulin like growth factor-I (IGF-I) at 11-13 weeks in preeclampsia. Prenat Diagn 30: 1026-1031, 2010.
31. Sifakis S, Akolekar R, Kappou D, Mantas N and Nicolaides KH: Maternal serum insulin-like growth factor binding protein-1 (IGFBP-1) at 11-13 weeks in preeclampsia. Prenat Diagn 31: 196-201, 2011.
32. Sifakis S, Akolekar R, Kappou D, Mantas N and Nicolaides KH: Maternal serum insulin-like growth factor binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia. J Hum Hypertens 26: 253-258, 2012
33. Sifakis S, Akolekar R, Kappou D, Mantas N and Nicolaides KH: Maternal serum insulin like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol 161: 30-33, 2012
34. Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O and Spandidos DA: Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res 21: 31-36, 2011
35. Koukoura O, Sifakis S, Zaravinos A, et al: Aberrant methylation of IGF2 is associated with loss of imprinting in placentas from pregnancies complicated with fetal growth restriction. Int J Mol Med 28: 481-487, 2011
36. Watson AJ, Hogan A, Hahnel A, Wiemer KE and Schultz GA: Expression of growth factor ligand and receptor genes in the preimplantation bovine embryo. Mol Reprod Dev 31: 87-95, 1992.
37. Watson AJ, Watson PH, Arcellana-Panlilio M, et al: A growth factor phenotype map for ovine preimplantation development. Biol Reprod 50: 725-733, 1994. (Pubitemid 24085211)
38. Zhang X, Kidder GM, Watson AJ, Schultz GA and Armstrong DT: Possible roles of insulin and insulin-like growth factors in rat preimplantation development: investigation of gene expression by reverse transcription- polymerase chain reaction. J Reprod Fertil 100: 375-380, 1994. (Pubitemid 24151367)
39. Lighten AD, Hardy K, Winston RM and Moore GE: Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev 47: 134-139, 1997. (Pubitemid 27188221)
40. Rotwein P, Pollock KM, Watson M and Milbrandt JD: Insulin-like growth factor gene expression during rat embryonic development. Endocrinology 121: 2141-2144, 1987. (Pubitemid 18016986)
41. Schlegel W, Halbauer D, Raimann A, et al: IGF expression patterns and regulation in growth plate chondrocytes. Mol Cell Endocrinol 327: 65-71, 2010.
42. Wang Y, Cheng Z, Elalieh HZ, et al: IGF1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihhpathway. J Bone Miner Res 26: 1437-46, 2011.
43. Parker EA, Hegde A, Buckley M, Barnes KM, Baron J and Nilsson O: Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage. J Endocrinol 194: 31-40, 2007. (Pubitemid 47162884)
44. Sadler TW (ed): Limbs. In: Langman's Medical Embryology. Lippincott Williams and Wilkins, Philadephia, PA, 12th edition, pp151-152.
45. Sifakis S, Basel D, Ianakiev P, Kilpatrick M and Tsipouras P: Distal limb malformations: underlying mechanisms and clinical associations. Clin Genet 60: 165-172, 2001. (Pubitemid 32982813)
46. Kaplowitz PB, D'Ercole AJ and Underwood LE: Stimulation of embryonic mouse limb bud mesenchymal cell growth by peptide growth factors. J Cell Physiol 112: 353-359, 1982. (Pubitemid 12053091)
47. Bhaumick B and Bala RM: Receptors for insulin-like growth factors I and II in developing embryonic mouse limb bud. Bioch Bioph Acta 927: 117-128, 1987. (Pubitemid 17232103)
48. Geduspan JS and Solursh M: Effects of the mesonephros and insulin-like growth factor I on chondrogenesis of limb explants. Dev Biol 156: 500-508, 1993. (Pubitemid 23122314)
49. Streck RD, Wood TL, Hsu MS and Pintar JE: Insulin-like growth factor I and II and insulin-like growth factor binding protein 2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs. Dev Biol 151: 586-596, 1992.
50. Ralphs JR, Wylie L and Hill DJ: Distribution of insulin-like growth factor peptides in the developing chick embryo. Development 109: 51-58, 1990.
51. Geduspan JS, Padanilam BJ and Solursh M: Coordinate expression of IGF-I and its receptor during limb outgrowth. Dev Dyn 195: 67-73, 1992. (Pubitemid 23034185)
52. Mc Queeney K and Dealy CN: Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs. Growth Horm IGF Res 11: 346-363, 2001. (Pubitemid 34428878)
53. van Kleffens M, Groffen C, Rosato RR, et al: mRNA expression patterns of the IGF system during mouse limb bud development determined by whole mount in situ hybridization. Mol Cell Endocrinol 138: 151-161, 1998. (Pubitemid 28302026)
54. Wang E, Wang J, Chin E, Zhou J and Bondy CA: Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis. Endocrinology 136: 2741-2751, 1995.
55. Allan GJ, Flint DJ, Darling SM, Geh J and Patel K: Altered expression of insulin-like growth factor 1 and insulin-like growth factor binding proteins 2 and 5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity. Anat Embryol (Berl) 202: 1-11, 2000. (Pubitemid 30411731)
56. Lok F, Owens JA, Mundy L, Robinson JS and Owens PC: Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation. Am J Physiol 270: R1148-R1155, 1996.
57. Mathews LS, Hammer RE, Behringer RR, et al: Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123: 2827-2833, 1988. (Pubitemid 19012801)
58. Dealy CN and Kosher RA: Studies on insulin-like growth factor-I and insulin in chick limb morphogenesis. Dev Dyn 202: 67-79, 1995.
59. Mesiano S, Young IR, Baxter RC, Hintz RL, Browne CA and Thorburn GD: Effect of hypophysectomy with and without thyroxine replacement on growth and circulating concentrations of insulin-like growth factors I and II in the fetal lamb. Endocrinology 120: 1821-1830, 1987. (Pubitemid 17069210)
60. Bikle D, Majumdar S, Laib A, et al: The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16: 2320-2329, 2001. (Pubitemid 33104725)
61. Burghardt AJ, Wang Y, Elalieh H, et al: Evaluation of fetal bone structure and mineralization in IGF-I deficient mice using synchrotron radiation microtomography and Fourier transform infrared spectroscopy. Bone 40: 160-168, 2007. (Pubitemid 44842022)
62. Woods KA, Camacho-Hübner C, Barter D, Clark AJL and Savage MO: Insulin-like growth factor I gene deletion causing intrauterine growth retardation an severe short stature. Acta Paediatr Suppl 423: 39-45, 1997. (Pubitemid 27511886)
63. Netchine I, Azzi S, Housang M, et al: Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metab 94: 3913-3921, 2009.
64. Bonapace G, Concolino D, Formicola S and Strisciuglio P: A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 40: 913-917, 2003. (Pubitemid 38117542)
65. Coutinho DC, Coletta RR, Costa EM, et al: Polymorphisms identified in the upstream core polyadenylation signal of IGF1 gene exon 6 do not cause pre- and postnatal growth impairment. J Clin Endocrinol Metab 92: 4889-4892, 2007. (Pubitemid 350223474)
66. van Duyvenvoorde HA, van Setten PA, Walenkamp MJE, et al: Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene. J Clin Endocrinol Metab 95: E363-E367, 2010.
67. van Duyvenvoorde HA, van Doorn J, Koenig J, et al: The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein. Growth Hormone IGF Res 21: 44-50, 2011.
68. Abuzzahab MJ, Schneider A, Goddard A, et al: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349: 2211-2222, 2003. (Pubitemid 37485137)
69. Kawashima Y, Kanzaki S, Yang F, et al: Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab 90: 4679-4687, 2005. (Pubitemid 41159358)
70. Raile K, Klammt J, Schneider A, et al: Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor I receptor (IGF1R) mutation: implication for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab 91: 2264-2271, 2006. (Pubitemid 43855016)
71. Walenkamp MJ, van der Kamp HJ, Pereira AM, et al: A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab 91: 3062-3070, 2006. (Pubitemid 44271756)
72. Inagaki K, Tiulpakov A, Rubtsov P, et al: A familial insulin-like growth factor I receptor mutant leads to short stature: clinical and biochemical characterization. J Clin Endocrinol Metab 92: 1542-1548, 2007. (Pubitemid 46556437)
73. Kruis T, Klammt J, Galli-Tsinopoulou A, et al: Heterozygous mutation within a kinase-conserved motif of the insulin-like growth factor I receptor causes intrauterine and postnatal growth retardation. J Clin Endocrinol Metab 95: 1137-1142, 2010.
74. Wallborn T, Wüller S, Klammt J, et al: A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplasmic reticulum and results in intrauterine and postnatal growth retardation. J Clin Endocrinol Metab 95: 2316-2324, 2010.
75. Choi JH, Kang M, Kim GH, et al: Clinical and functional characteristics of a novel heterozygous mutation of the IGF1R gene and IGF1R haploinsufficiency due to terminal 15q26.2->qter deletion in patients with intrauterine growth retardation and postnatal catch-up growth failure. J Clin Endocrinol Metab 96: E130-E134, 2011.
76. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chrétien M and Butler MG: An infant with deletion of the distal long arm of chromosome 15 (q26.1 - qter) and loss of insulin-like growth factor I receptor gene. Am J Med Genet 38: 74-79, 1991.
77. Walemkamp MJ, de Muinck Keizer-Schrama SM, de Mos M, et al: Successful long-term growth hormone therapy in a girl with haploinsufficiency in the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. J Clin Endocrinol Metab 93: 2421-2425, 2008.
78. Fang P, Schwartz ID, Johnson BD, et al: Familial short stature caused by haploinsufficiency of the insulin-like growth factor I receptor due to nonsense-mediated messenger ribonucleic acid decay. J Clin Endocrinol Metab 94: 1740-1747, 2009.
79. Ester WA, van Duyvenvoorde HA, de Wit CC, et al: Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype. J Clin Endocrinol Metab 94: 4717-4727, 2009.